Dissolution methodology for taste masked oral dosage forms

Journal of Controlled Release

Volumn 173, Issue 1, 2014, Pages 32-42

  Gittings, Sally ^a   Turnbull, Neil ^b   Roberts, Clive J ^a   Gershkovich, Pavel ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

Biopharmaceutics; Biorelevant dissolution; Oral absorption; Paediatric; Pharmacokinetics; Taste masking

Indexed keywords

ACTIVE PHARMACEUTICAL INGREDIENTS; BIOPHARMACEUTICS; COMPETITIVE INHIBITION; DISSOLUTION TESTING; IN-VITRO DISSOLUTION; ORAL ABSORPTION; PHARMACOKINETIC PROFILES; TASTE-MASKING;

DRUG PRODUCTS; PEDIATRICS; PHARMACOKINETICS; PHYSIOLOGY;

DISSOLUTION;

EXCIPIENT; SWEETENING AGENT;

BITTER TASTE; COMPETITIVE INHIBITION; DISSOLUTION; DRUG ABSORPTION; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; EVALUATION; GASTROINTESTINAL ABSORPTION; HUMAN; IN VITRO STUDY; MASKING; METHODOLOGY; MOUTH CAVITY; PRIORITY JOURNAL; REVIEW; TASTE MASKING;

BIOPHARMACEUTICS; BIORELEVANT DISSOLUTION; ORAL ABSORPTION; PAEDIATRIC; PHARMACOKINETICS; TASTE MASKING;

ADMINISTRATION, ORAL; EQUIPMENT DESIGN; HUMANS; MOUTH; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; SOLUBILITY; SWEETENING AGENTS; TASTE; TECHNOLOGY, PHARMACEUTICAL;

EID: 84887796585     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2013.10.030     Document Type: Review

References (135)

1. Merck & Co., Inc. The Merck Manual. Pharmacokinetics in the elderly Available from: http://www.merckmanuals.com/professional/geriatrics/drug- therapy-in-the-elderly/pharmacokinetics-in-the-elderly.html 2012-11/06/2013
2. Merck, Co. Inc. The Merck Manual. Pharmacokinetics in children Available from: http://www.merckmanuals.com/professional/pediatrics/principles-of-drug- treatment-in-children/pharmacokinetics-in-children.html 2012-11/06/2013
3. J. Breitkreutz, and J. Boos Paediatric and geriatric drug delivery Expert Opin. Drug Deliv. 4 1 2007 37 45 (Pubitemid 46117485)
4. L.V. Allen Jr. Dosage form design and development Clin. Ther. 30 11 2008 2102 2111
5. M. Aulton Aulton's Pharmaceutics. The Design and Manufacture of Medicines Third edition 2007 Churchill Livingstone Elsevier London
6. T. Nunn, and J. Williams Formulation of medicines for children Br. J. Clin. Pharmacol. 59 6 2005 674 676 (Pubitemid 40835500)
7. R.G. Strickley Pediatric drugs - a review of commercially available oral formulations J. Pharm. Sci. 97 5 2008 1731 1774
8. H. Sohi, Y. Sultana, and R.K. Khar Taste masking technologies in oral pharmaceuticals: recent developments and approaches Drug Dev. Ind. Pharm. 30 5 2004 429 448 (Pubitemid 38821855)
9. B. Albertini Characterization and taste-masking evaluation of acetaminophen granules: comparison between different preparation methods in a high-shear mixer Eur. J. Pharm. Sci. 21 2-3 2004 295 303 (Pubitemid 38156165)
10. A. Fini Fast dispersible/slow releasing ibuprofen tablets Eur. J. Pharm. Biopharm. 69 1 2008 335 341
11. T. Harada A new method for evaluating the bitterness of medicines in development using a taste sensor and a disintegration testing apparatus Chem. Pharm. Bull. 58 8 2010 1009 1014
12. R. Sheshala Formulation and in vivo evaluation of ondansetron orally disintegrating tablets using different superdisintegrants Arch. Pharm. Res. 34 11 2011 1945 1956
13. M. de Aguiar Oral sustained release nystatin tablets for the treatment of oral candidiasis: formulation development and validation of UV spectrophotometric analytical methodology for content determination Drug Dev. Ind. Pharm. 36 5 2010 594 600
14. J. Vaassen, K. Bartscher, and J. Breitkreutz Taste masked lipid pellets with enhanced release of hydrophobic active ingredient Int. J. Pharm. 429 1-2 2012 99 103
15. R. Witzleb Solid lipid extrusion with small die diameters - electrostatic charging, taste masking and continuous production Eur. J. Pharm. Biopharm. 77 1 2011 170 177
16. S. Qi, D. Deutsch, and D.Q.M. Craig An investigation into the mechanisms of drug release from taste-masking fatty acid microspheres J. Pharm. Sci. 97 9 2008 3842 3854
17. Y. Nitanai A novel mathematical model considering change of diffusion coefficient for predicting dissolution behavior of acetaminophen from wax matrix dosage form Int. J. Pharm. 428 1-2 2012 82 90
18. M. Maniruzzaman Taste masking of paracetamol by hot-melt extrusion: an in vitro and in vivo evaluation Eur. J. Pharm. Biopharm. 80 2 2012 433 442
19. M. Ostrowski, E. Wilkowska, and T. Baczek Impact of pharmaceutical dosage form on stability and dissolution of roxithromycin Cen. Eur. J. Med. 5 1 2010 83 90
20. T. Hamashita Granulation of core particles suitable for film coating by agitation fluidized bed I. Optimum formulation for core particles and development of a novel friability test method Chem. Pharm. Bull. 55 8 2007 1169 1174 (Pubitemid 47344968)
21. T. Hamashita Granulation of core particles suitable for film coating by agitation fluidized bed II. A proposal of a rapid dissolution test for evaluation of bitter taste of ibuprofen Chem. Pharm. Bull. 56 7 2008 883 887 (Pubitemid 351949697)
22. M. Guhmann Development of oral taste masked diclofenac formulations using a taste sensing system Int. J. Pharm. 438 1-2 2012 81 90
23. D.D. Douroumis, A. Gryczke, and S. Schminke Development and evaluation of cetirizine HCl taste-masked oral disintegrating tablets AAPS PharmSciTech 12 1 2011 141 151
24. S.A. Randale Rapidly disintegrating tablets containing taste masked metoclopramide hydrochloride prepared by extrusion-precipitation method Chem. Pharm. Bull. 58 4 2010 443 448
25. Y.D. Yan Preparation and evaluation of taste-masked donepezil hydrochloride orally disintegrating tablets Biol. Pharm. Bull. 33 8 2010 1364 1370
26. P.P. Shah Design and optimization of artemether microparticles for bitter taste masking Acta Pharma. 58 4 2008 379 392
27. P.P. Shah Design and optimization of mefloquine hydrochloride microparticles for bitter taste masking AAPS PharmSciTech 9 2 2008 377 389
28. N. Guffon Developing a new formulation of sodium phenylbutyrate Arch. Dis. Child. 97 12 2012 1081 1085
29. A.R. Menjoge, and M.G. Kulkarni Designing a self-associated cationic polymer for enhanced compatibility, palatability, and gastric release of cefuroxime axetil Biomacromolecules 8 2 2007 532 542 (Pubitemid 46323270)
30. R. Sheshala, N. Khan, and Y. Darwis Formulation and optimization of orally disintegrating tablets of sumatriptan succinate Chem. Pharm. Bull. 59 8 2011 920 928
31. S. Shah, S. Madan, and S.S. Agrawal Formulation and evaluation of microsphere based oro dispersible tablets of itopride HCl Daru J. Pharm. Sci. 20 2012
32. Y. Shirai Role of low-substituted hydroxypropylcellulose in dissolution and bioavailability of novel fine granule system for masking bitter taste Biol. Pharm. Bull. 17 3 1994 427 431 (Pubitemid 24155149)
33. Y. Shirai Influence of heat treatment on dissolution and masking degree of bitter taste for a novel fine granule system Chem. Pharm. Bull. 44 2 1996 399 402 (Pubitemid 26087069)
34. Y. Shirai A novel fine granule system for masking bitter taste Biol. Pharm. Bull. 16 2 1993 172 177 (Pubitemid 23129194)
35. S.P. Li Evaluation of the film-coating properties of a hydroxyethyl cellulose/hydroxypropyl methylcellulose polymer system Drug Dev. Ind. Pharm. 28 4 2002 389 401 (Pubitemid 34547877)
36. T.H.H. Thia Development and evaluation of taste-masked drug for paediatric medicines - application to acetaminophen Int. J. Pharm. 434 1-2 2012 235 242
37. H.J. Robson, D.Q.M. Craig, and D. Deutsch An investigation into the release of cefuroxime axetil from taste-masked stearic acid microspheres - Part 1: the influence of the dissolution medium on the drug release profile and the physical integrity of the microspheres Int. J. Pharm. 190 2 1999 183 192 (Pubitemid 29509912)
38. H. Robson, D.Q.M. Craig, and D. Deutsch An investigation into the release of cefuroxime axetil from taste-masked stearic acid microspheres. II. The effects of buffer composition on drug release Int. J. Pharm. 195 1-2 2000 137 145 (Pubitemid 30089498)
39. C.W. Lee Preparation of bitter taste masked cetirizine dihydrochloride/beta-cyclodextrin inclusion complex by supercritical antisolvent (SAS) process J. Supercrit. Fluids 55 1 2010 348 357
40. F.M. Mady Enhancement of the aqueous solubility and masking the bitter taste of famotidine using drug/SBE-beta-CyD/povidone K30 complexation approach J. Pharm. Sci. 99 10 2010 4285 4294
41. A.R. Patel, and P.R. Vavia Preparation and evaluation of taste masked famotidine formulation using drug/beta-cyclodextrin/polymer ternary complexation approach AAPS PharmSciTech 9 2 2008 544 550
42. Q.Y. Tan Design and evaluation of an economic taste-masked dispersible tablet of pyridostigmine bromide, a highly soluble drug with an extremely bitter taste Chem. Pharm. Bull. 60 12 2012 1514 1521
43. P.P. Shah, and R.C. Mashru Palatable reconstitutable dry suspension of artemether for flexible pediatric dosing using cyclodextrin inclusion complexation Pharm. Dev. Technol. 15 3 2010 276 285
44. P.P. Shah, and R.C. Mashru Formulation and evaluation of taste masked oral reconstitutable suspension of primaquine phosphate AAPS PharmSciTech 9 3 2008 1025 1030
45. S.C. Jagdale Formulation and in vitro evaluation of taste-masked oro-dispersible dosage form of diltiazem hydrochloride Braz. J. Pharm. Sci. 47 4 2011 907 916
46. R. Agarwal, R. Mittal, and A. Singh Studies of ion-exchange resin complex of chloroquine phosphate Drug Dev. Ind. Pharm. 26 7 2000 773 776 (Pubitemid 30397333)
47. X.F. Yu A simple and novel method for preparing the taste masking levofloxacin microsphere suspension Afr. J. Pharm. Pharmacol. 6 22 2012 1617 1624
48. M.K. Chun, and H.K. Choi Preparation and characterization of enrofloxacin/carbopol complex in aqueous solution Arch. Pharm. Res. 27 6 2004 670 675
49. S. Patra Taste masking of etoricoxib by using ion-exchange resin Pharm. Dev. Technol. 15 5 2010 511 517
50. J.H. Lee A nanohybrid system for taste masking of sildenafil Int. J. Nanomedicine 7 2012 1635 1649
51. Z. Rahman Chlorpheniramine tannate complexes: physicochemical, chemometric, and taste masking evaluation Int. J. Pharm. 436 1-2 2012 582 592
52. C. Agresti Specific interactions between diphenhydramine and alpha-helical poly(glutamic acid) - a new ion-pairing complex for taste masking and pH-controlled diphenhydramine release Eur. J. Pharm. Biopharm. 70 1 2008 226 233
53. K. Bhise, S. Shaikh, and D. Bora Taste mask, design and evaluation of an oral formulation using ion exchange resin as drug carrier AAPS PharmSciTech 9 2 2008 557 562
54. Z. Rahman Tannate complexes of antihistaminic drug: sustained release and taste masking approaches Int. J. Pharm. 422 1-2 2012 91 100
55. R.B. Shah Complexation between risperidone and amberlite resin by various methods of preparation and binding study Drug Dev. Ind. Pharm. 35 12 2009 1409 1418
56. M.A. Tawakkul Complexation of risperidone with a taste-masking resin: novel application of near infra-red and chemical imaging to evaluate complexes Pharm. Dev. Technol. 14 4 2009 409 421
57. D. Shukla Fabrication and evaluation of taste masked resinate of risperidone and its orally disintegrating tablets Chem. Pharm. Bull. 57 4 2009 337 345
58. M. Malladi Design and evaluation of taste masked dextromethorphan hydrobromide oral disintegrating tablets Acta Pharma. 60 3 2010 267 280
59. E. Roblegg Reformulation of a codeine phosphate liquid controlled-release product Drug Dev. Ind. Pharm. 36 12 2010 1454 1462
60. T. Yoshida Salting-out taste-masking system generates lag time with subsequent immediate release Int. J. Pharm. 365 1-2 2009 81 88
61. T. Yoshida Mechanism of controlled drug release from a salting-out taste-masking system J. Control. Release 131 1 2008 47 53
62. K. Shiino Preparation and evaluation of granules with pH-dependent release by melt granulation Int. J. Pharm. 431 1-2 2012 70 77
63. R.B. Kulkarni, and P.D. Amin Masking of unpleasant gustatory sensation by cross-linking of dehydrated paracetamol alginate pellets produced by extrusion-spheronization Drug Dev. Ind. Pharm. 34 2 2008 199 205 (Pubitemid 351317147)
64. A. Gryczke Development and evaluation of orally disintegrating tablets (ODTs) containing Ibuprofen granules prepared by hot melt extrusion Colloids Surf. B Biointerfaces 86 2 2011 275 284
65. R.V. Haware Development of a melting tablet containing promethazine HCl against motion sickness AAPS PharmSciTech 9 3 2008 1006 1015
66. P.P. Shah, and R.C. Mashru Development and evaluation of artemether taste masked rapid disintegrating tablets with improved dissolution using solid dispersion technique AAPS PharmSciTech 9 2 2008 494 500
67. D.A. Chiappetta Indinavir-loaded pH-sensitive microparticles for taste masking: toward extemporaneous pediatric anti-HIV/AIDS liquid formulations with improved patient compliance AAPS PharmSciTech 10 1 2009 1 6
68. T. Yajima Particle design for taste-masking using a spray-congealing technique Chem. Pharm. Bull. 44 1 1996 187 191 (Pubitemid 26053955)
69. P.P. Shah, and R.C. Mashru Influence of chitosan crosslinking on bitterness of mefloquine hydrochloride microparticles using central composite design J. Pharm. Sci. 98 2 2009 690 703
70. A. Barkley, S. Levine, and C. Signorino The evolution and evaluation of tablet coatings Tablets and Capsules 2006 CSC Publishing Inc. St Paul, MN, USA
71. V. Anand The latest trends in the taste assessment of pharmaceuticals Drug Discov. Today 12 5-6 2007 257 265
72. K. Woertz A comparative study on two electronic tongues for pharmaceutical formulation development J. Pharm. Biomed. Anal. 55 2 2011 272 281
73. F. Cilurzo Nicotine fast dissolving films made of maltodextrins: a feasibility study AAPS PharmSciTech 11 4 2010 1511 1517
74. J.D. Martin Siewert, Cynthia K. Brown, Vinod P. Shah, Jean-Marc Aiache, Nobuo Aoyagi, Dennis Bashaw, Cynthia Brown, William Brown, Diane Burgess, John Crison, Patrick DeLuca, Ruzica Djerki, Thomas Foster, Kirsti Gjellan, Vivian Gray, Ajaz Hussain, Tom Ingallinera, James Klancke, Johannes Kraemer, Henning Kristensen, Kofi Kumi, Christian Leuner, Jobst Limberg, Petra Loos, Lenny Margulis, Patrick Marroum, Helga Moeller, Bernd Mueller, Martin Mueller-Zsigmondy, Ngozi Okafo, Larry Ouderkirk, Shravan Parsi, Saeed Qureshi, Joseph Robinson, Vinod Shah, Martin Siewert, Ramana Uppoor, and Roger Williams FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms AAPS PharmSciTech 4 1 2003 43 52
75. T. Ishikawa Preparation and evaluation of tablets rapidly disintegrating in saliva containing bitter-taste-masked granules by the compression method Chem. Pharm. Bull. 47 10 1999 1451 1454 (Pubitemid 29510317)
76. P.C. Kayumba Quinine sulphate pellets for flexible pediatric drug dosing: formulation development and evaluation of taste-masking efficiency using the electronic tongue Eur. J. Pharm. Biopharm. 66 3 2007 460 465 (Pubitemid 46756222)
77. M.G. MKulkarni, Menjoge, and R. Anupa Taste masked pharmaceutical compositions comprising bitter drug and pH sensitive polymer P. Nixon, Vandehye 2005 Council of Scientific and Industrial Research New Delhi: United States
78. F.Q. Li Cetirizine dihydrochloride loaded microparticles design using ionotropic cross-linked chitosan nanoparticles by spray-drying method Arch. Pharm. Res. 33 12 2010 1967 1973
79. C.G. Wilson The behavior of a fast-dissolving dosage from (expidet) followed by gamma-scintigraphy Int. J. Pharm. 40 1-2 1987 119 123
80. J. Chen, L. Engelen, and I. ebrary Food oral processing [electronic resource]: fundamentals of eating and sensory perception Jianshe Chen, Lina Engelen, 2012 Wiley Blackwell
81. E.N. Marieb Essentials of Human Anatomy and Physiology Tenth ed. 2012 Pearson San Francisco, USA
82. P. Abrahams, J. Craven, and J. Lumley Illustrated Clinical Anatomy Second ed. 2011 Hodder Arnold London, UK
83. K.L. Moore, A.M.R. Agur, and A.F. Dalley Essential Clinical Anatomy 4th ed. 2011 Lippincott Williams & Wikins, Wolters Kluwer Baltimore, USA
84. A.H. Shojaei Buccal mucosa as a route for systemic drug delivery: a review J. Pharm. Pharm. Sci. 1 1 1998 15 30
85. H. Zhang, J. Zhang, and J.B. Streisand Oral mucosal drug delivery - clinical pharmacokinetics and therapeutic applications Clin. Pharmacokinet. 41 9 2002 661 680
86. H. Sohi Critical evaluation of permeation enhancers for oral mucosal drug delivery Drug Dev. Ind. Pharm. 36 3 2010 254 282
87. F.C. Holsinger, and D.T. Bui Anatomy, function and evaluation of the salivary glands E.N. Myers, R.L. Ferris, Salivary Gland Disorders 2007 Springer Berlin, New York 1 16
88. C. Fenoll-Palomares Unstimulated salivary flow rate, pH and buffer capacity of saliva in healthy volunteers Rev. Esp. Enferm. Dig. 96 11 2004 773 778
89. D.J. Aframian, T. Davidowitz, and R. Benoliel The distribution of oral mucosal pH values in healthy saliva secretors Oral Dis. 12 4 2006 420 423 (Pubitemid 43926822)
90. J.D. Rudney, Z. Ji, and C.J. Larson The prediction of saliva swallowing frequency in humans from estimates of salivary flow-rate and the volume of saliva swallowed Arch. Oral Biol. 40 6 1995 507 512
91. E. Emekli-Alturfan Altered biochemical parameters in the saliva of patients with breast cancer Tohoku J. Exp. Med. 214 2 2008 89 96
92. F. Lagerlof, and C. Dawes The volume of saliva in the mouth before and after swallowing J. Dent. Res. 63 5 1984 618 621
93. K. Muller Measurement of saliva volume in the mouth of members of a trained sensory panel using a beetroot (Beta vulgaris) extract Food Qual. Prefer. 21 5 2010 569 574
94. L. Kalantzi Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies Pharm. Res. 23 1 2006 165 176 (Pubitemid 43214673)
95. T. Shpitzer A comprehensive salivary analysis for oral cancer diagnosis J. Cancer Res. Clin. Oncol. 133 9 2007 613 617 (Pubitemid 47077052)
96. J. Gibson, and J.A. Beeley Natural and synthetic saliva: a stimulating subject Biotechnol. Genet. Eng. Rev. 12 1994 39 61
97. J. Chandrashekar The receptors and cells for mammalian taste Nature 444 7117 2006 288 294 (Pubitemid 44764097)
98. British Pharmacopoeia Appendix X11 B. Dissolution Updated 20/05/2013 vol. V 2013 (Available from: http://www.pharmacopoeia.co.uk/bp2013updated/ixbin/bp. cgi?a=display&r=q7bhaXR0S-B&id=889)
99. J.B. Lo Formulation design and pharmaceutical development of a novel controlled release form of azithromycin for single-dose therapy Drug Dev. Ind. Pharm. 35 12 2009 1522 1529
100. H. Tasaki Effects of physicochemical properties of salting-out layer components on drug release Int. J. Pharm. 376 1-2 2009 13 21
101. S. Mohammad Efficacious formulation of anti-malarial dry suspension for pediatric use Afr. J. Pharm. Pharmacol. 6 36 2012 2629 2633
102. Y. Shahzad The evaluation of coated granules to mask the bitter taste of dihydroartemisinin Braz. J. Pharm. Sci. 47 2 2011 323 330
103. T. Mizumoto Formulation design of an oral, fast-disintegrating dosage form containing taste-masked particles of famotidine Chem. Pharm. Bull. 56 7 2008 946 950
104. T. Mizumoto Formulation design of taste-masked particles, including famotidine, for an oral fast-disintegrating dosage form Chem. Pharm. Bull. 56 4 2008 530 535 (Pubitemid 351520139)
105. J.B. Dressman Estimating drug solubility in the gastrointestinal tract Adv. Drug Deliv. Rev. 59 7 2007 591 602 (Pubitemid 47287780)
106. A. Okumu, M. DiMaso, and R. Loebenberg Dynamic dissolution testing to establish in vitro/in vivo correlations for montelukast sodium, a poorly soluble drug Pharm. Res. 25 12 2008 2778 2785
107. M. Vertzoni Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compounds Eur. J. Pharm. Biopharm. 60 3 2005 413 417 (Pubitemid 40922839)
108. T. Ogata Taste masking of propiverine hydrochloride by conversion to its free base Chem. Pharm. Bull. 60 8 2012 976 984
109. Ministry of Health Labour and Welfare Japanese Pharmacopoeia 15th edition 2007-19/06/2013 (Available from: http://jpdb.nihs.go.jp/jp15e/)
110. S. Khan Taste masking of ondansetron hydrochloride by polymer carrier system and formulation of rapid-disintegrating tablets AAPS PharmSciTech 8 2 2007
111. K. Kondo Preparation and evaluation of orally rapidly disintegrating tablets containing taste-masked particles using one-step dry-coated tablets technology Chem. Pharm. Bull. 59 10 2011 1214 1220
112. P.R. Delvadia, W.H. Barr, and H.T. Karnes A biorelevant in vitro release/permeation system for oral transmucosal dosage forms Int. J. Pharm. 430 1-2 2012 104 113
113. T. Yajima Method of evaluation of the bitterness of clarithromycin dry syrup Chem. Pharm. Bull. 50 2 2002 147 152 (Pubitemid 41694570)
114. D.A. Volpe Application of method suitability for drug permeability classification AAPS J. 12 4 2010 670 678
115. V.F. Patel, F. Liu, and M.B. Brown Modeling the oral cavity: in vitro and in vivo evaluations of buccal drug delivery systems J. Control. Release 161 3 2012 746 756
116. M. Lestari, J.A. Nicolazzo, and B.C. Finnin A novel flow through diffusion cell for assessing drug transport across the buccal mucosa in vitro J. Pharm. Sci. 98 12 2009 4577 4588
117. J. Malmborg, and B.A. Ploeger Predicting human exposure of active drug after oral prodrug administration, using a joined in vitro/in silico-in vivo extrapolation and physiologically-based pharmacokinetic modeling approach J. Pharmacol. Toxicol. Methods 67 3 2013 203 213
118. T. Goswami In silico model of drug permeability across sublingual mucosa Arch. Oral Biol. 58 5 2013 545 551
119. A. Kambayashi, and J.B. Dressman An in vitro-in silico-in vivo approach to predicting the oral pharmacokinetic profile of salts of weak acids: case example dantrolene Eur. J. Pharm. Biopharm. 84 1 2013
120. K.H. Grime, P. Barton, and D.F. McGinnity Application of in silico, in vitro and preclinical pharmacokinetic data for the effective and efficient prediction of human pharmacokinetics Mol. Pharm. 10 4 2013 1191 1206
121. N.A. Hosea, and H.M. Jones Predicting pharmacokinetic profiles using in silico derived parameters Mol. Pharm. 10 4 2013 1207 1215
122. M. McAllister Dynamic dissolution: a step closer to predictive dissolution testing? Mol. Pharm. 7 5 2010 1374 1387
123. S.N. Battachar, and L. Burns The artificial stomach and duodenum (ASD): a physiologically relevant in vitro dissolution tool The 2nd Electronic Conference on Pharmaceutical Sciences Sciforum: Sciforum Electronic Conferences Series 2012
124. S.N. Bhattachar Effect of gastric pH on the pharmacokinetics of a BCS Class II compound in dogs: utilization of an artificial stomach and duodenum dissolution model and GastroPlus™, simulations to predict absorption J. Pharm. Sci. 100 11 2011 4756 4765
125. S.R. Carino, D.C. Sperry, and M. Hawley Relative bioavailability of three different solid forms of PNU-141659 as determined with the artificial stomach-duodenum model J. Pharm. Sci. 99 9 2010 3923 3930
126. S.R. Carino, D.C. Sperry, and M. Hawley Relative bioavailability estimation of carbamazepine crystal forms using an artificial stomach-duodenum model J. Pharm. Sci. 95 1 2006 116 125
127. D.E. Ebeln Gastrointestinal models (TIM) with high predictive power [cited 2013 10/06/2013]; Available from: http://www.tno.nl/content.cfm?context= thema&content=markt-product&laag1=891&laag2=195&laag3= 320&item-id=1100&Taal=2 2013
128. P.A. Dickinson An investigation into the utility of a multi-compartmental, dynamic, system of the upper gastrointestinal tract to support formulation development and establish bioequivalence of poorly soluble drugs AAPS J. 14 2 2012 196 205
129. T.A. Naylor Use of a gastro-intestinal model and GastroPlus™ for the prediction of in vivo performance Ind. Pharm. 12 2006 9 12
130. J.M. Cardot, E. Beyssac, and M. Alric In vitro-in vivo correlation: importance of dissolution in IVIVC Dissolut. Technol. 14 1 2007 15 19
131. S. Tenjarla Release of 5-aminosalicylate from an MMX mesalamine tablet during transit through a simulated gastrointestinal tract system Adv. Ther. 24 4 2007 826 840 (Pubitemid 351612256)
132. R. Lobenberg, and G.L. Amidon Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards Eur. J. Pharm. Biopharm. 50 1 2000 3 12 (Pubitemid 30326685)
133. S. Souliman A level A in vitro/in vivo correlation in fasted and fed states using different methods: applied to solid immediate release oral dosage form Eur. J. Pharm. Sci. 27 1 2006 72 79 (Pubitemid 41728257)
134. S. Blanquet A dynamic artificial gastrointestinal system for studying the behavior of orally administered drug dosage forms under various physiological conditions Pharm. Res. 21 4 2004 585 591 (Pubitemid 38457280)
135. S. Souliman Investigation of the biopharmaceutical behavior of theophylline hydrophilic matrix tablets using USP methods and an artificial digestive system Drug Dev. Ind. Pharm. 33 4 2007 475 483 (Pubitemid 46808777)